The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2013

Filed:

Aug. 05, 2011
Applicants:

Eugene A. Woltering, Kenner, LA (US);

Conrad A. Hornick, Makawao, HI (US);

Amy E. Myers, Austin, TX (US);

Inventors:

Eugene A. Woltering, Kenner, LA (US);

Conrad A. Hornick, Makawao, HI (US);

Amy E. Myers, Austin, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/746 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Noni juice and a protein-free, alcohol precipitate of Noni juice inhibited angiogenesis in in vitro human angiogenesis models. When growth medium contained Noni juice at least over the range from about 2.5% to about 33% (by volume), angiogenesis was blocked. Moreover, Noni juice and an ethanol precipitate were able to destroy a pre-existing angiogenic response as well as prevent the development of new vessels. Noni juice was effective in inhibiting the growth of angiogenic vessels from breast cancer explants. It will also be effective in treating cancers and non-cancerous diseases whose response includes an increase in angiogenesis, e.g., retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, and psoriasis. In an initial experiment, Noni juice was effective in treating lesions associated with psoriasis. The primary antiangiogenic component is believed to be a carbohydrate with a molecular weight less than about 6000 Daltons. In an initial experiment, oral administration of Noni juice appeared to adversely affect the antiangiogenic component(s) in the juice.


Find Patent Forward Citations

Loading…